Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07096011 · ClinicalTrials.gov registry record
Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants
A clinical trial of Metabolism and Energy Expenditure, sponsored by Pennington Biomedical Research Center.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT07096011: Recruiting study of Metabolism and Energy Expenditure, sponsored by Pennington Biomedical Research Center.
NCT07096011 is a study of Metabolism and Energy Expenditure that is actively recruiting participants, run by Pennington Biomedical Research Center. The registered enrollment target is 40 participants, below the 13,264-participant average among 19 other Metabolism trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07096011, a study of Metabolism and Energy Expenditure, is actively recruiting participants, sponsored by Pennington Biomedical Research Center.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to understand how infants metabolize different meals and to develop clinical tools which identify infants as having two different phenotypes. The phenotypes are the 1) metabolic "thriftiness" and 2) the metabolic flexibility.
Primary Outcome
Percent difference from baseline to postprandial energy expenditure
Conditions Studied
Interventions
- OTHER Meal Test - Human Milk
- OTHER Meal Test - Infant Formula
Study Locations (1)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-07-28 |
| Est. Completion | 2027-05 |
What NCT07096011 shows while recruiting
NCT07096011 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 13,264-participant average among 19 other Metabolism trials with a reported enrollment target (100% lower).
The record links to 6 conditions, with Metabolism appearing as the primary indexed condition, and to 2 interventions - of which Meal Test - Human Milk is the first listed.
NCT07096011 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT07096011 about?
NCT07096011 is a clinical study titled "Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants". The purpose of this research study is to understand how infants metabolize different meals and to develop clinical tools which identify infants as having two different phenotypes. The phenotypes are the 1) metabolic "thriftiness" and 2) the metabolic flexibility.
What is the current status of trial NCT07096011?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-07-28. Estimated completion is 2027-05.
What conditions does trial NCT07096011 study?
This clinical trial studies the following conditions: Metabolism, Energy Expenditure, Infant Body Composition and Metabolism, Infant Formula, Human Milk, Breast Milk.
What interventions are being tested in trial NCT07096011?
The interventions under investigation include: Meal Test - Human Milk (OTHER), Meal Test - Infant Formula (OTHER).
Who is sponsoring clinical trial NCT07096011?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07096011 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07096011's enrollment target sits among peer trials
40 8th of 19 higher than 12 of 19 other Metabolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women
RECRUITING · NA
-
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
RECRUITING · Phase 2
-
Caloric Balance Markers Study
RECRUITING
-
Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells
RECRUITING · NA
-
Personalized Responses to Dietary Composition Trial 3
RECRUITING · NA
-
Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI